MDH1B
Putative malate dehydrogenase 1B
Also known as: FLJ25341, MDH1B_HUMAN, RP11-95H11
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q5I0G3
- Gene
- MDH1B
- Ensembl
- ENSG00000138400
- Chromosome
- 2
- Canonical length
- 518 aa
- Protein class
- Metabolic proteins, Predicted intracellular proteins
OverviewNCBI Gene
Predicted to enable L-malate dehydrogenase (NAD+) activity. Predicted to be involved in NADH metabolic process; dicarboxylic acid metabolic process; and tricarboxylic acid cycle. [provided by Alliance of Genome Resources, Apr 2025]
Canonical amino-acid sequenceUniProt
518 residues, UniProt reviewed canonical sequence.
>Q5I0G3|MDH1B
1 MAKFVIAGRA DCPYYAKTEL VADYLQKNLP DFRIHKITQR PEVWEDWLKD VCEKNKWSHK
61 NSPIIWRELL DRGGKGLLLG GYNEFLEHAQ LYYDVTSSMT TELMMVIAQE NLGAHIEKEQ
121 EEEALKTCIN PLQVWITSAS APACYNLIPI LTSGEVFGMH TEISITLFDN KQAEEHLKSL
181 VVETQDLASP VLRSVSICTK VEEAFRQAHV IVVLDDSTNK EVFTLEDCLR SRVPLCRLYG
241 YLIEKNAHES VRVIVGGRTF VNLKTVLLMR YAPRIAHNII AVALGVEGEA KAILARKLKT
301 APSYIKDVII WGNISGNNYV DLRKTRVYRY ESAIWGPLHY SRPVLNLIFD SEWVKREFVA
361 ILKNLTTTGR QFGGILAAHS IATTLKYWYH GSPPGEIVSL GILSEGQFGI PKGIVFSMPV
421 KFENGTWVVL TDLKDVEISE QIMTRMTSDL IQEKLVALGD KIHFQPYQSG HKDLVPDEEK
481 NLAMSDAAEF PNQIPQTTFE KPQSLEFLNE FEGKTVESLocalizationUniProt · AlphaFold · HPA
Whether an antibody against MDH1B can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.28
- Highest tissue expression
- 23 nTPM
Expression across tissuesHPA
Tissue
- testis: 23 nTPM
- fallopian tube: 21 nTPM
- choroid plexus: 20 nTPM
- pituitary gland: 9.1 nTPM
- retina: 7.9 nTPM
- thyroid gland: 4.7 nTPM
Single-cell type
- late primary spermatocytes: 348 nCPM
- early spermatids: 159 nCPM
- respiratory ciliated cells: 127 nCPM
- fallopian tube ciliated cells: 117 nCPM
- ependymal cells: 79 nCPM
- endometrial ciliated cells: 64 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- choroid plexus: 32 nTPM
- midbrain: 10 nTPM
- medulla oblongata: 7.8 nTPM
- spinal cord: 6 nTPM
- white matter: 5.1 nTPM
- hypothalamus: 4.6 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.18
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.45
- DepMap mean gene effect
- -0.03
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MDH1B as an antibody target. Whether an autoantibody or antibody against MDH1B could matter depends on whether native MDH1B is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MDH1B is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label MDH1B as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...